Dublin, Jan. 15, 2025 (GLOBE NEWSWIRE) — The “Elastomeric Infusion Pumps Market Size, Share & Trends Analysis Report By Product, By Application, By End-use, By Region, And Segment Forecasts, 2025 – 2030” report has been added to ResearchAndMarkets.com’s offering.
The global elastomeric infusion pumps market size was estimated at USD 679.8 million in 2024 and is projected to grow at a CAGR of 7.2% from 2025 to 2030
The rising incidence of chronic diseases such as cancer, diabetes, and cardiovascular disorders is a significant driver for market growth. According to statistics from the World Health Organization (WHO), chronic diseases are the leading cause of mortality worldwide, accounting for 71% of all deaths globally. This led to a higher demand for continuous drug delivery systems such as elastomeric pumps to ensure effective treatment and management of these conditions.
The growing demand for home healthcare solutions is a crucial factor driving the elastomeric infusion pumps industry. Patients prefer therapies that enable them to administer medications at home, and the portability and user-friendliness of elastomeric pumps cater to this need. This trend is amplified by the aging population’s increasing requirement for long-term treatment of chronic conditions. According to a study published in October 2024, Osteomyelitis affects around 50,000 people annually in the U.S., with higher incidence in children, older adults, and males. Vertebrae and long bones are the most commonly involved sites. It also shows that males are more susceptible to Osteomyelitis than females, as evidenced by the current research and other published data on the disease.
Manufacturers are focusing on enhancing elastomeric infusion pump technologies to drive market growth. These advancements involve greater accuracy, longer infusion durations, developing pumps with improved features, and accessible designs. These innovations aim to cater to the diverse needs of patients and healthcare providers, enhancing the efficiency of elastomeric infusion pumps and making them dependable and secure.
In September 2024, research published in the Journal of Biosciences and Medicines presented a theoretical model for elastomeric pumps, which deliver medications through a catheter. The study accurately reproduced clinical flow rates and identified a toxicity bump related to the sphere’s radius. The researchers concluded that by optimizing pump properties, infusion times can be controlled while minimizing toxicity effects.
The increasing push to reduce opioid dependence and improve patient access to alternative pain management solutions has been a major driver in healthcare policy changes. In November 2024, Avanos Medical, Inc. reported that the Centers for Medicare and Medicaid Services has finalized its Medicare Hospital Outpatient Prospective Payment System and Ambulatory Surgical Center Payment System regulations for 2025, set to take effect on January 1, 2025. This update introduces the NOPAIN Act, which requires Medicare to provide distinct payments for eligible non-opioid medications and devices to improve patient access to pain management solutions in hospital outpatient and surgical center environments.
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19’s impact and how to sustain in these fast-evolving markets
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 100 |
| Forecast Period | 2024 – 2030 |
| Estimated Market Value (USD) in 2024 | $679.8 million |
| Forecasted Market Value (USD) by 2030 | $1020 million |
| Compound Annual Growth Rate | 7.2% |
| Regions Covered | Global |
Market Dynamics
Market driver analysis
- Increasing prevalence of chronic diseases
- Rising number of orthopedic surgeries
- Technological advancements in elastomeric infusion pumps
Market restraint analysis
- High cost of elastomeric infusion pumps
- Regulatory standards
Elastomeric Infusion Pumps Market Analysis Tools
- Industry Analysis – Porter’s
- PESTEL Analysis
Competitive Landscape
- Baxter
- Fresenius Kabi AG
- B. Braun SE
- Ambu A/S
- Leventon, S.A.U.
- NIPRO
- Terumo Corporation
- AVNS
- Vygon Group
- Smiths Group plc
Global Elastomeric Infusion Pumps Market Report Segmentation
Product Outlook (Revenue, USD Million, 2018 – 2030)
- Continuous Rate Elastomeric Infusion Pumps
- Variable Rate Elastomeric Infusion Pumps
Application Outlook (Revenue, USD Million, 2018 – 2030)
- Pain Management
- Chemotherapy
- Antibiotic/Antiviral Therapy
- Others
End-use Outlook (Revenue, USD Million, 2018 – 2030)
- Hospitals
- Ambulatory Surgical Centers
- Others
Regional Outlook (Revenue, USD Million, 2018 – 2030)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- South Korea
- Australia
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
For more information about this report visit https://www.researchandmarkets.com/r/t7m2ao
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Elastomeric Infusion Pumps Market
